Bruce Power announces milestone in medical Lu-177 production

Framatome announced that it has inaugurated a new workshop dedicated to the fabrication of fuel for research reactors and targets for medical isotopes at the company’s Romans-sur-Isère site...

Southern Nuclear recently loaded nuclear fuel with uranium-235 enriched up to 6 percent—higher than the usual 3–5 percent enrichment—into Vogtle-2 to test it through irradiation....

ANS Executive Director/CEO Craig Piercy recently spoke on nuclear power’s potential for answering today’s energy demands as part of the Distinguished Lecture Series at the University of...

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at...

Framatome’s enhanced accident tolerant fuel assemblies recently completed a third 18-month fuel cycle at Southern Nuclear’s Vogtle-2 plant—the first of this type of fuel to reach this...

The Department of Energy announced contracts yesterday for six companies to perform high-assay low-enriched uranium (HALEU) deconversion and to transform enriched uranium hexafluoride (UF6) to...

TerraPower Isotopes, a subsidiary of Bellevue, Wash.–based TerraPower, announced it is now producing actinium-225 at commercial scale, making the medical isotope available to the...